Research area
Phase 1 Breast Cancer trials
A breast cancer study may be testing a medication that is still investigational. It may instead pair therapies that already exist, or look at a different way of handling screening or supportive care. At Phase 1 Cancer Trials, we help you, or the person you care for, learn whether one of these studies could suit you.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Phase 1 breast cancer studies in numbers
- Phase 1 breast cancer studies recruiting in the U.S.
- 246
- states with a study site
- 46
- studies that accept healthy volunteers
- 2
Source: ClinicalTrials.gov. Data processed .
Phase 1 breast cancer studies recruiting now
As of November 17, 2026, 246 Phase 1 breast cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry. This is what they have in common.
What they test
- medications212
- biologics such as vaccines or antibodies36
- procedures21
- diagnostic tests10
- radiation9
A study can test more than one.
Main purpose
- treating a condition218
- diagnosis14
- supportive care4
- other purposes3
Phase
- Early Phase 119
- Phase 1133
- Phase 1/294
Who runs them
- industry149
- university, hospital or other91
- government6
Who they enroll
- adults (18 to 64)246
- older adults (65 and over)245
- children (under 18)4
2 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 246 studies.
Recently updated Phase 1 breast cancer studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Phase 1
- Ages 12 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda, MD · Fairway, KS
- Registry record
- NCT04222413 · updated
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Totus Medicines
- Recruiting in
- Boston, MA · Calverton, MD · Chicago, IL · and 5 more U.S. locations
- Registry record
- NCT05683418 · updated
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Recruiting in
- Ann Arbor, MI · Aurora, CO · Austin, TX · and 23 more U.S. locations
- Registry record
- NCT06253871 · updated
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Recruiting in
- Duarte, CA · Glen Burnie, MD · Grand Rapids, MI · and 9 more U.S. locations
- Registry record
- NCT07020117 · updated
Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Recruiting in
- Houston, TX
- Registry record
- NCT07553390 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Boston, MA · Cerritos, CA · Fairfax, VA · and 17 more U.S. locations
- Registry record
- NCT06324357 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in the United States on ClinicalTrials.gov.
What breast cancer studies look at
Breast cancer research takes several forms. Some studies test medications that are still investigational, some give existing therapies together, and some examine ways of handling screening or supportive care. Each one is built around a single, specific question. That question shapes what you would be asked to do, so the tasks in one trial will not match those in another.
Whatever a study is testing is investigational. In plain terms, how well it works is not yet settled and its risks are not fully understood. Researchers run the study precisely to learn those things.
Who may be able to take part
Each breast cancer study writes its own list of requirements. Your age may be on it. So may your health history, any medications you are currently taking, and how the cancer affects you. People without the condition are also enrolled in some studies.
Working out whether you are eligible is not your job, or the job of the person caring for you. That check happens during a screening visit and is carried out by the study team. Our guide to eligibility and screening explains the process.
What taking part usually involves
A first conversation
The first step is a conversation with a coordinator. You hear a general outline of the study and can ask whatever you need to. Nothing else goes ahead until that has happened.
Informed consent
You receive the complete details in writing from the study team, and the known risks are set out there too. Read them through. Saying yes or no is then up to you.
Screening
Screening consists of health questions and tests. From the results, it becomes clear whether this particular study suits you. Being screened does not always lead to taking part.
Study visits
Should you decide to take part, the team keeps track of your health at visits booked on a set schedule. Leaving is always open to you. You can withdraw whenever you choose.
Questions about Phase 1 breast cancer studies
Do I need a diagnosis to join a study about breast cancer?
There is no single answer, because studies differ on this point. Some will only take people whose diagnosis has already been confirmed. In others, that assessment is part of screening itself. The study team will explain which of the two applies in your case.
Would I have to change the care I receive now?
Whether current care can continue depends on the study. Some allow it and others do not. Please do not change any care on your own. The study doctor reviews this with you, and you are welcome to discuss it with your own doctor before you decide.
Is there a cost to take part?
In general, a participant is not charged for study visits, study tests or the study medication. We go through this in more detail on a separate page, where you can read more about costs.
Ask about Phase 1 breast cancer studies
Asking about a study commits you to nothing. Give us a few details, and a coordinator will be in touch with you.
Independent information
- Breast Cancer — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)